Laurion Capital Management »

Humacyte shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.6k 12k 0.78

More positions owned by Laurion Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Advanced Micro Devices Call Option (AMD)
Norfolk Southern (NSC)
Electronic Arts (EA)
Applied Materials Call Option (AMAT)
Dell Technologies CL C (DELL)
Warner Bros Discovery Com Ser A (WBD)
Corning Incorporated Call Option (GLW)
Bridgebio Pharma (BBIO)
Robinhood Mkts Com Cl A (HOOD)
Datadog Cl A Com Call Option (DDOG)
Carvana Cl A (CVNA)
Qualcomm (QCOM)
Intel Corporation Call Option (INTC)
Cloudflare Cl A Com Call Option (NET)

View all positions for Laurion Capital Management

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte